METHOD FOR PREDICTING THERAPEUTIC EFFECT OF COMBINATION CHEMOTHERAPY

摘要

Disclosed is an anti-tumor agent which can exhibit a superior life-prolonging effect on progressive gastric cancer patients, on whom conventional therapy methods cannot exhibit a satisfactory life-prolonging effect, compared to those of the conventional therapy methods, when the patients are selected by employing a thymidylate synthase as a measure.  The anti-tumor agent comprises a tegafur-gimeracil-(oteracil potassium) combination preparation and cisplatin.